Document is current
Any future updates will be listed below
-
Authors
Zhou, Xinsheng
Liu, Yixin
Liu, Xuan
Song, Xu
Li, Sijie
Chen, Peng
Jiang, Xiaotao
Li, Yongyin
-
Funding
Funding for this research was provided by:
National Natural Sciences Foundation of China (32370986)
Natural Science Foundation of Guangdong Province (2023A1515010259)
Health Care Major Project of Guangzhou (202206080001)
- License Information
-
More Information
Article History
Received: 9 January 2025
Accepted: 10 April 2025
First Online: 1 May 2025
Declarations
:
: This article does not include any research conducted by any authors on human participants. The study was approved by the Ethics Review Committee of Southern Medical University.
: Not applicable.
: The corresponding author, X.J. holds the patent of anti-GPC3 N-terminal monoclonal antibody production (CN113527500 A).
